Curcumin and silibinin inhibit telomerase expression in T47D human breast cancer cells

77Citations
Citations of this article
76Readers
Mendeley users who have this article in their library.

Abstract

Background: Telomerase has been considered as an attractive molecular target for breast cancer therapy. The main objective of this work is to assess the inhibitory effects of silibinin and curcumin, two herbal substances, on telomerase gene expression in breast cancer cells. Materials and Methods: For determination of cell viability tetrazolium-based assays were conducted after 24, 48, and 72 h exposure times and expression of human telomerase reverse transcriptase gene was measured with real-time PCR. Results: Each compound exerted cytotoxic effects on T47D cells and inhibited telomerase gene expression, both in a time-and dose-dependent manner. The mixture of curcumin and silibinin showed relatively more inhibitory effect on growth of T47D cells and hTERT gene expression as compared with either agent alone. Conclusions: These findings suggest that cell viability along with hTERT gene expression in breast cancer cells could be reduced by curcumin and silibinin.

Cite

CITATION STYLE

APA

Nasiri, M., Zarghami, N., Koshki, K. N., Mollazadeh, M., Moghaddam, M. P., Yamchi, M. R., … Alibakhshi, A. (2013). Curcumin and silibinin inhibit telomerase expression in T47D human breast cancer cells. Asian Pacific Journal of Cancer Prevention, 14(6), 3449–3453. https://doi.org/10.7314/APJCP.2013.14.6.3449

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free